Sort
50,496 grants matching “lung cancer”
Antidotes against HCI-induced chronic lung injury
$440,014John D. Catravas · Old Dominion University · U01 · FY2022 · ES
Designs and Methods for Sequence-Based Validation Analysis
$440,000Lue Ping Na Zhao · Fred Hutchinson Cancer Research Center · R01 · FY2010 · MH
Designs and Methods for Sequence-Based Validation Analysis
$440,000Lue Ping Na Zhao · Fred Hutchinson Cancer Research Center · R01 · FY2009 · MH
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
$439,992Steven A Webber · Vanderbilt University Medical Center · K12 · FY2022 · HD
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
$439,992Michael Rutledge Debaun · Vanderbilt University Medical Center · K12 · FY2023 · HD
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
$439,992Steven A Webber · Vanderbilt University Medical Center · K12 · FY2021 · HD
The function of cyclin C in tumorigenesis
$439,962Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2019 · CA
TOPOGRAPHY AND GENETICS OF SMOKING AND NICOTINE DEPENDENCE IN AMERICAN INDIANS
$439,907Jeffrey A Henderson · University Of Washington · P50 · FY2011 · CA
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
$439,902Andrew Jackson · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Colorado Biomarkers Development Laboratory
$439,901University Of Colorado Denver · U01 · FY2004 · CA
Molecular and cellular mechanism of IL-17 signaling in tumorigenesis
$439,900Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · CA
Experimental Cancer Imaging Research Program (ECIRP)
$439,877John D Hazle · University Of Tx Md Anderson Can Ctr · U24 · FY2011 · CA
Biomarker Reference Laboratory, EDRN
$439,835William E. Grizzle · University Of Alabama At Birmingham · U24 · FY2007 · CA
Dissecting and Targeting RB1-Mutant Osteosarcoma
$439,831Dung-Fang Lee · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$439,813Willy Hugo · University Of California Los Angeles · R01 · FY2024 · CA
STAT3 is a Critical Regulator of Tumor Cell Plasticity
$439,755Nancy C. Reich · State University New York Stony Brook · R01 · FY2023 · CA
STAT3 is a Critical Regulator of Tumor Cell Plasticity
$439,755Nancy C. Reich · State University New York Stony Brook · R01 · FY2022 · CA
Development of caveolae-targeted antibody-drug conjugates
$439,725Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · P01 · FY2021 · CA
Dissecting and targeting PAK4 in Ewing sarcoma
$439,708Jason Yustein · Emory University · R01 · FY2025 · CA
Role of BMDCs in Solid Tumor Growth and Relapse
$439,670Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2008 · CA
Novel approaches to study immune responses to post translational modifications for cancer detection
$439,654Joshua Labaer · Arizona State University-Tempe Campus · U01 · FY2019 · CA
Purchase of AB Sciex QTRAP 5500 System
$439,654Papasani V Subbaiah · University Of Illinois At Chicago · S10 · FY2012 · OD
The CXCR3 Chemokine System in Cancer Immunotherapy
$439,649Andrew D Luster · Massachusetts General Hospital · R01 · FY2017 · CA
Mechanisms of Differential Cellular Protection
$439,637Valter D. Longo · University Of Southern California · P01 · FY2015 · AG
Research Project
$439,619Terrance L. Albrecht · Wayne State University · U54 · FY2014 · CA